U.S. market Closed. Opens in 11 hours 59 minutes

RAPT | RAPT Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/A1.53M3.81M5.04MN/AN/AN/A
Cost of Revenue3.55M2.81M996.00KN/A1.33MN/AN/A
Gross Profit-3.55M-1.28M2.82M5.04M-1.33MN/AN/A
Operating Expenses123.51M87.32M73.02M58.26M43.63M36.95M29.33M
Selling, General & Admin22.51M20.24M16.04M12.77M8.72M5.18M3.71M
Research & Development101.00M67.08M56.98M45.48M34.91M31.77M25.62M
Other Operating ExpensesN/A1.96M5.00K1.31M1.29M800.00KN/A
Operating Income-127.06M-85.80M-69.21M-53.21M-43.63M-36.95M-29.33M
Other Expenses / Income10.26M1.96M5.00K1.31M1.29M800.00K216.00K
Before Tax Income-116.80M-83.84M-69.20M-51.90M-42.34M-36.15M-29.11M
Income Tax ExpensesN/A-1.96M-996.00K990.00K660.00K800.00KN/A
Net Income-116.80M-81.88M-68.21M-52.89M-43.00M-36.15M-29.11M
Interest ExpensesN/A-1.05MN/AN/AN/AN/AN/A
Basic Shares Outstanding38.34M32.54M27.39M24.13M21.83M17.33M14.46M
Diluted Shares Outstanding38.34M32.54M27.39M24.13M21.83M17.33M14.46M
EBITDA-123.51M-85.80M-69.21M-53.21M-43.63M-35.71M-27.73M
EBITDA Margin0.00%-5,618.53%-1,815.08%-1,055.41%0.00%0.00%0.00%
EBIT-116.80M-84.89M-69.20M-51.90M-42.34M-35.35M-29.11M
EBIT Margin0.00%-5,558.94%-1,814.95%-1,029.39%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙